Strata Critical Medical, Inc. (SRTA) Cash Flow Statement
Strata Critical Medical, Inc. (SRTA) generated -$36.0M of operating cash flow over the twelve months to 2026-06-30, spent $13.5M on capital expenditure and had free cash flow of -$49.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SRTAStrata Critical Medical, Inc.Follow SRTA — free
—
Price chart with a free account
- Market cap
- 412.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2021 Sep 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -15.6 | -37.1 | -32.3 | -2.5 | -48.9 | -36.0 | |
| Capital expenditure | 0.3 | 0.7 | 2.1 | 33.0 | 11.0 | -13.5 | |
| Free cash flow | -15.9 | -37.9 | -34.5 | -35.5 | -59.9 | -49.5 | |
| Share repurchases | — | — | — | 0.2 | 0.0 | — | |
| Stock-based compensation | 9.6 | 8.3 | 12.5 | 19.9 | 17.8 | — |
USD millions · SEC XBRL
Strata Critical Medical, Inc. — questions
- What is Strata Critical Medical, Inc.'s operating cash flow?
- -$36.0M over the twelve months to 2026-06-30.
- How much does Strata Critical Medical, Inc. spend on capital expenditure?
- $13.5M over the twelve months to 2026-06-30.
- What is Strata Critical Medical, Inc.'s free cash flow?
- -$49.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Strata Critical Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.